Skip to main content
Erschienen in: Supportive Care in Cancer 7/2011

01.07.2011 | Review Article

Systematic review: malfunction of totally implantable venous access devices in cancer patients

verfasst von: Godelieve Alice Goossens, Marguerite Stas, Martine Jérôme, Philip Moons

Erschienen in: Supportive Care in Cancer | Ausgabe 7/2011

Einloggen, um Zugang zu erhalten

Abstract

Purpose

Malfunction of totally implantable venous access devices is a common complication. The purpose was to identify definitions used to describe malfunction and to investigate the incidence of malfunction in different types of port and catheter designs.

Methods

Relevant studies were identified in PubMed that were published between January 1993 and February 2011. Empirical studies reporting functional outcomes in adults and where, at least 95% of the studied population consisted of onco-hematology patients with a newly inserted chest or arm port, were selected. The following data were extracted: patient and totally implantable venous access devices (TIVAD) characteristics, study design, definitions of malfunction, and functional outcomes. Two independent reviewers assessed the methodological quality of the series.

Results

Of the 4,886 potentially relevant articles, 57 were selected, involving 14,311 TIVADs. Twenty-nine percent of the studies explicitly defined malfunction. Malfunction incidence rates were expressed in six different ways, including the proportion of affected devices per inserted devices (incidence 0–47%); the number of affected devices per 1,000 catheter days (incidence 0–2.24 per 1,000 catheter days); and the number of malfunctions over the total number of accessing attempts (incidence 0–26%).

Conclusions

Heterogeneity in the definitions used to describe device malfunction was evident. A broad range in the reported incidence of malfunction and in the kind of calculation and reporting methods was also found. Methodological quality of the studies was often poor. Standardization of definitions and accurate outcome measurement is needed. Calculation and report of malfunction incidence should be based on prospective data collected at the moment of an accession attempt.
Literatur
1.
Zurück zum Zitat Akahane A, Sone M, Ehara S, Kato K, Tanaka R, Nakasato T (2010) Subclavian vein versus arm vein for totally implantable central venous port for patients with head and neck cancer: a retrospective comparative analysis. Cardiovasc Intervent Radiol. doi:10.1007/s00270-010-0051-4 PubMed Akahane A, Sone M, Ehara S, Kato K, Tanaka R, Nakasato T (2010) Subclavian vein versus arm vein for totally implantable central venous port for patients with head and neck cancer: a retrospective comparative analysis. Cardiovasc Intervent Radiol. doi:10.​1007/​s00270-010-0051-4 PubMed
2.
Zurück zum Zitat Araujo C, Silva JP, Antunes P, Fernandes JM, Dias C, Pereira H, Dias T, Fougo JL (2008) A comparative study between two central veins for the introduction of totally implantable venous access devices in 1201 cancer patients. Eur J Surg Oncol 34:222–226PubMed Araujo C, Silva JP, Antunes P, Fernandes JM, Dias C, Pereira H, Dias T, Fougo JL (2008) A comparative study between two central veins for the introduction of totally implantable venous access devices in 1201 cancer patients. Eur J Surg Oncol 34:222–226PubMed
3.
Zurück zum Zitat Biffi R, De Braud F, Orsi F, Pozzi S, Arnaldi P, Goldhirsch A, Rotmensz N, Robertson C, Bellomi M, Andreoni B (2001) A randomized, prospective trial of central venous ports connected to standard open-ended or Groshong catheters in adult oncology patients. Cancer 92:1204–1212PubMedCrossRef Biffi R, De Braud F, Orsi F, Pozzi S, Arnaldi P, Goldhirsch A, Rotmensz N, Robertson C, Bellomi M, Andreoni B (2001) A randomized, prospective trial of central venous ports connected to standard open-ended or Groshong catheters in adult oncology patients. Cancer 92:1204–1212PubMedCrossRef
4.
Zurück zum Zitat Biffi R, De Braud F, Orsi F, Pozzi S, Mauri S, Goldhirsch A, Nole F, Andreoni B (1998) Totally implantable central venous access ports for long-term chemotherapy. A prospective study analyzing complications and costs of 333 devices with a minimum follow-up of 180 days. Ann Oncol 9:767–773PubMedCrossRef Biffi R, De Braud F, Orsi F, Pozzi S, Mauri S, Goldhirsch A, Nole F, Andreoni B (1998) Totally implantable central venous access ports for long-term chemotherapy. A prospective study analyzing complications and costs of 333 devices with a minimum follow-up of 180 days. Ann Oncol 9:767–773PubMedCrossRef
5.
Zurück zum Zitat Biffi R, Martinelli G, Pozzi S, Cinieri S, Cocorocchio E, Peccatori F, Ferrucci PF, Pistorio R, Andreoni B (1999) Totally implantable central venous access ports for high-dose chemotherapy administration and autologous stem cell transplantation: analysis of overall and septic complications in 68 cases using a single type of device. Bone Marrow Transplant 24:89–93PubMedCrossRef Biffi R, Martinelli G, Pozzi S, Cinieri S, Cocorocchio E, Peccatori F, Ferrucci PF, Pistorio R, Andreoni B (1999) Totally implantable central venous access ports for high-dose chemotherapy administration and autologous stem cell transplantation: analysis of overall and septic complications in 68 cases using a single type of device. Bone Marrow Transplant 24:89–93PubMedCrossRef
6.
Zurück zum Zitat Biffi R, Pittiruti M, Gillet JP, Fobe D, Hermanne JP, Pescio M, Gourlia A, Collet K, Battelli C, Cenciarelli S (2002) Valved central venous catheter connected to subcutaneous port: a multicenter phase IV study based on a cohort of 50 oncology patients. J Vasc Access 3:147–153PubMed Biffi R, Pittiruti M, Gillet JP, Fobe D, Hermanne JP, Pescio M, Gourlia A, Collet K, Battelli C, Cenciarelli S (2002) Valved central venous catheter connected to subcutaneous port: a multicenter phase IV study based on a cohort of 50 oncology patients. J Vasc Access 3:147–153PubMed
7.
Zurück zum Zitat Bodner LJ, Nosher JL, Patel KM, Siegel RL, Biswal R, Gribbin CE, Tokarz R (2000) Peripheral venous access ports: outcomes analysis in 109 patients. Cardiovasc Interv Radiol 23:187–193CrossRef Bodner LJ, Nosher JL, Patel KM, Siegel RL, Biswal R, Gribbin CE, Tokarz R (2000) Peripheral venous access ports: outcomes analysis in 109 patients. Cardiovasc Interv Radiol 23:187–193CrossRef
8.
Zurück zum Zitat Brown DF, Muirhead MJ, Travis PM, Vire SR, Weller J, Hauer-Jensen M (1997) Mode of chemotherapy does not affect complications with an implantable venous access device. Cancer 80:966–972PubMedCrossRef Brown DF, Muirhead MJ, Travis PM, Vire SR, Weller J, Hauer-Jensen M (1997) Mode of chemotherapy does not affect complications with an implantable venous access device. Cancer 80:966–972PubMedCrossRef
9.
Zurück zum Zitat Burbridge B, Krieger E, Stoneham G (2000) Arm placement of the cook titanium Petite Vital-Port: results of radiologic placement in 125 patients with cancer. Can Assoc Radiol J 51:163–169PubMed Burbridge B, Krieger E, Stoneham G (2000) Arm placement of the cook titanium Petite Vital-Port: results of radiologic placement in 125 patients with cancer. Can Assoc Radiol J 51:163–169PubMed
10.
Zurück zum Zitat Caers J, Fontaine C, Vinh-Hung V, De Mey J, Ponnet G, Oost C, Lamote J, De Greve J, Van Camp B, Lacor P (2005) Catheter tip position as a risk factor for thrombosis associated with the use of subcutaneous infusion ports. Support Care Cancer 13:325–331PubMedCrossRef Caers J, Fontaine C, Vinh-Hung V, De Mey J, Ponnet G, Oost C, Lamote J, De Greve J, Van Camp B, Lacor P (2005) Catheter tip position as a risk factor for thrombosis associated with the use of subcutaneous infusion ports. Support Care Cancer 13:325–331PubMedCrossRef
11.
Zurück zum Zitat Carlo JT, Lamont JP, McCarty TM, Livingston S, Kuhn JA (2004) A prospective randomized trial demonstrating valved implantable ports have fewer complications and lower overall cost than nonvalved implantable ports. Am J Surg 188:722–727PubMedCrossRef Carlo JT, Lamont JP, McCarty TM, Livingston S, Kuhn JA (2004) A prospective randomized trial demonstrating valved implantable ports have fewer complications and lower overall cost than nonvalved implantable ports. Am J Surg 188:722–727PubMedCrossRef
12.
Zurück zum Zitat Carre MC, Lopez Vega JM, Carles J, Lizon J, Villar A, Lera SA, Alastrue A, Rull M, Van der HC, Aguilo J (1994) Central venous brachial catheter (P.A.S. Port TM) and catheter scanning system (Cath-Finder TM). J Surg Oncol 55:190–193PubMedCrossRef Carre MC, Lopez Vega JM, Carles J, Lizon J, Villar A, Lera SA, Alastrue A, Rull M, Van der HC, Aguilo J (1994) Central venous brachial catheter (P.A.S. Port TM) and catheter scanning system (Cath-Finder TM). J Surg Oncol 55:190–193PubMedCrossRef
13.
Zurück zum Zitat Chang HM, Hsieh CB, Hsieh HF, Chen TW, Chen CJ, Chan DC, Yu JC, Liu YC, Shen KL (2006) An alternative technique for totally implantable central venous access devices. A retrospective study of 1311 cases. Eur J Surg Oncol 32:90–93PubMedCrossRef Chang HM, Hsieh CB, Hsieh HF, Chen TW, Chen CJ, Chan DC, Yu JC, Liu YC, Shen KL (2006) An alternative technique for totally implantable central venous access devices. A retrospective study of 1311 cases. Eur J Surg Oncol 32:90–93PubMedCrossRef
14.
Zurück zum Zitat Chen PT, Sung CS, Wang CC, Chan KH, Chang WK, Hsu WH (2007) Experience of anesthesiologists with percutaneous nonangiographic venous access. J Clin Anesth 19:609–615PubMedCrossRef Chen PT, Sung CS, Wang CC, Chan KH, Chang WK, Hsu WH (2007) Experience of anesthesiologists with percutaneous nonangiographic venous access. J Clin Anesth 19:609–615PubMedCrossRef
15.
Zurück zum Zitat Conessa C, Talfer S, Herve S, Chollet O, Poncet JL (2002) Cephalic vein access for implantable venous access devices. Technique and long-term follow-up. Rev Laryngol Otol Rhinol (Bord) 123:143–148 Conessa C, Talfer S, Herve S, Chollet O, Poncet JL (2002) Cephalic vein access for implantable venous access devices. Technique and long-term follow-up. Rev Laryngol Otol Rhinol (Bord) 123:143–148
16.
Zurück zum Zitat Cunningham MJ, Collins MB, Kredentser DC, Malfetano JH (1996) Peripheral infusion ports for central venous access in patients with gynecologic malignancies. Gynecol Oncol 60:397–399PubMedCrossRef Cunningham MJ, Collins MB, Kredentser DC, Malfetano JH (1996) Peripheral infusion ports for central venous access in patients with gynecologic malignancies. Gynecol Oncol 60:397–399PubMedCrossRef
17.
Zurück zum Zitat de Gregorio MA, Miguelena JM, Fernandez JA, de Gregorio C, Tres A, Alfonso ER (1996) Subcutaneous ports in the radiology suite: an effective and safe procedure for care in cancer patients. Eur Radiol 6:748–752PubMedCrossRef de Gregorio MA, Miguelena JM, Fernandez JA, de Gregorio C, Tres A, Alfonso ER (1996) Subcutaneous ports in the radiology suite: an effective and safe procedure for care in cancer patients. Eur Radiol 6:748–752PubMedCrossRef
18.
Zurück zum Zitat Dede D, Akmangit I, Yildirim ZN, Sanverdi E, Sayin B (2008) Ultrasonography and fluoroscopy-guided insertion of chest ports. Eur J Surg Oncol 34:1340–1343PubMed Dede D, Akmangit I, Yildirim ZN, Sanverdi E, Sayin B (2008) Ultrasonography and fluoroscopy-guided insertion of chest ports. Eur J Surg Oncol 34:1340–1343PubMed
19.
Zurück zum Zitat Deppe G, Kahn ML, Malviya VK, Malone JM Jr, Christensen CW (1996) Experience with the P.A.S.-PORT venous access device in patients with gynecologic malignancies. Gynecol Oncol 62:340–343PubMedCrossRef Deppe G, Kahn ML, Malviya VK, Malone JM Jr, Christensen CW (1996) Experience with the P.A.S.-PORT venous access device in patients with gynecologic malignancies. Gynecol Oncol 62:340–343PubMedCrossRef
20.
Zurück zum Zitat Di Carlo I, Cordio S, La Greca G, Privitera G, Russello D, Puleo S, Latteri F (2001) Totally implantable venous access devices implanted surgically: a retrospective study on early and late complications. Arch Surg 136:1050–1053PubMedCrossRef Di Carlo I, Cordio S, La Greca G, Privitera G, Russello D, Puleo S, Latteri F (2001) Totally implantable venous access devices implanted surgically: a retrospective study on early and late complications. Arch Surg 136:1050–1053PubMedCrossRef
21.
Zurück zum Zitat Estes JM, Rocconi R, Straughn JM, Bhoola S, Leath CA, Alvarez RD, Kilgore LC, Huh WK (2003) Complications of indwelling venous access devices in patients with gynecologic malignancies. Gynecol Oncol 91:591–595PubMedCrossRef Estes JM, Rocconi R, Straughn JM, Bhoola S, Leath CA, Alvarez RD, Kilgore LC, Huh WK (2003) Complications of indwelling venous access devices in patients with gynecologic malignancies. Gynecol Oncol 91:591–595PubMedCrossRef
22.
Zurück zum Zitat Frank JL, Garb JL, Halla B, Reed WP Jr (2001) Ionic implantation of silicone chronic venous access devices does not alter thrombotic complications: a double-blinded, randomized clinical trial. Surgery 129:547–551PubMedCrossRef Frank JL, Garb JL, Halla B, Reed WP Jr (2001) Ionic implantation of silicone chronic venous access devices does not alter thrombotic complications: a double-blinded, randomized clinical trial. Surgery 129:547–551PubMedCrossRef
23.
Zurück zum Zitat Gleeson NC, Fiorica JV, Mark JE, Pinelli DM, Hoffman MS, Roberts WS, Cavanagh D (1993) Externalized Groshong catheters and Hickman ports for central venous access in gynecologic oncology patients. Gynecol Oncol 51:372–376PubMedCrossRef Gleeson NC, Fiorica JV, Mark JE, Pinelli DM, Hoffman MS, Roberts WS, Cavanagh D (1993) Externalized Groshong catheters and Hickman ports for central venous access in gynecologic oncology patients. Gynecol Oncol 51:372–376PubMedCrossRef
24.
Zurück zum Zitat Goossens GA, Verbeeck G, Moons P, Sermeus W, De Wever I, Stas M (2008) Functional evaluation of conventional 'Celsite' venous ports versus 'Vortex' ports with a tangential outlet: a prospective randomised pilot study. Support Care Cancer 16:1367–1374PubMedCrossRef Goossens GA, Verbeeck G, Moons P, Sermeus W, De Wever I, Stas M (2008) Functional evaluation of conventional 'Celsite' venous ports versus 'Vortex' ports with a tangential outlet: a prospective randomised pilot study. Support Care Cancer 16:1367–1374PubMedCrossRef
25.
Zurück zum Zitat Groebli Y, Wutrich P, Safa M, Tschantz P, Callewaert G, Piguet D (1999) Utility and complications of permanent venous access devices (PVAD) in oncological treatments. Follow-up of 100 cases. Panminerva Med 41:89–92PubMed Groebli Y, Wutrich P, Safa M, Tschantz P, Callewaert G, Piguet D (1999) Utility and complications of permanent venous access devices (PVAD) in oncological treatments. Follow-up of 100 cases. Panminerva Med 41:89–92PubMed
26.
Zurück zum Zitat Hartkamp A, van Boxtel AJ, Zonnenberg BA, Witteveen PO (2000) Totally implantable venous access devices: evaluation of complications and a prospective comparative study of two different port systems. Neth J Med 57:215–223PubMedCrossRef Hartkamp A, van Boxtel AJ, Zonnenberg BA, Witteveen PO (2000) Totally implantable venous access devices: evaluation of complications and a prospective comparative study of two different port systems. Neth J Med 57:215–223PubMedCrossRef
27.
Zurück zum Zitat Heibl C, Trommet V, Burgstaller S, Mayrbaeurl B, Baldinger C, Koplmuller R, Kuhr T, Wimmer L, Thaler J (2010) Complications associated with the use of Port-a-Caths in patients with malignant or haematological disease: a single-centre prospective analysis. Eur J Cancer Care (Engl) 19:676–681CrossRef Heibl C, Trommet V, Burgstaller S, Mayrbaeurl B, Baldinger C, Koplmuller R, Kuhr T, Wimmer L, Thaler J (2010) Complications associated with the use of Port-a-Caths in patients with malignant or haematological disease: a single-centre prospective analysis. Eur J Cancer Care (Engl) 19:676–681CrossRef
28.
Zurück zum Zitat Hoekstra A, Bassot V, Bertoglio S, Bobin JY, Delassus P, Egeli R, Khayat D, Ranchere JY, Santini J, Segol P (1993) Clinical evaluation of the CORDIS vascular access port systems: a multicenter study. Med Oncol Tumor Pharmacother 10:131–138PubMed Hoekstra A, Bassot V, Bertoglio S, Bobin JY, Delassus P, Egeli R, Khayat D, Ranchere JY, Santini J, Segol P (1993) Clinical evaluation of the CORDIS vascular access port systems: a multicenter study. Med Oncol Tumor Pharmacother 10:131–138PubMed
30.
Zurück zum Zitat Johansson E, Bjorkholm M, Bjorvell H, Hast R, Takolander R, Olofsson P, Backman L, Weitzberg E, Engervall P (2004) Totally implantable subcutaneous port system versus central venous catheter placed before induction chemotherapy in patients with acute leukaemia-a randomized study. Support Care Cancer 12:99–105PubMedCrossRef Johansson E, Bjorkholm M, Bjorvell H, Hast R, Takolander R, Olofsson P, Backman L, Weitzberg E, Engervall P (2004) Totally implantable subcutaneous port system versus central venous catheter placed before induction chemotherapy in patients with acute leukaemia-a randomized study. Support Care Cancer 12:99–105PubMedCrossRef
31.
Zurück zum Zitat Labourey JL, Lacroix P, Genet D, Gobeaux F, Martin J, Venat-Bouvet L, Lavau-Denes S, Maubon A, Tubiana-Mathieu N (2004) Thrombotic complications of implanted central venous access devices: prospective evaluation. Bull Cancer 91:431–436PubMed Labourey JL, Lacroix P, Genet D, Gobeaux F, Martin J, Venat-Bouvet L, Lavau-Denes S, Maubon A, Tubiana-Mathieu N (2004) Thrombotic complications of implanted central venous access devices: prospective evaluation. Bull Cancer 91:431–436PubMed
32.
Zurück zum Zitat Lemmers NW, Gels ME, Sleijfer DT, Plukker JT, van der Graaf WT, de Langen ZJ, Droste JH, Koops HS, Hoekstra HJ (1996) Complications of venous access ports in 132 patients with disseminated testicular cancer treated with polychemotherapy. J Clin Oncol 14:2916–2922PubMed Lemmers NW, Gels ME, Sleijfer DT, Plukker JT, van der Graaf WT, de Langen ZJ, Droste JH, Koops HS, Hoekstra HJ (1996) Complications of venous access ports in 132 patients with disseminated testicular cancer treated with polychemotherapy. J Clin Oncol 14:2916–2922PubMed
33.
Zurück zum Zitat Lenhart M, Chegini M, Gmeinwieser J, Manke C, Feuerbach S (1998) Radiologic implantation of central venous portal systems in the forearm. Rofo 169:189–194PubMed Lenhart M, Chegini M, Gmeinwieser J, Manke C, Feuerbach S (1998) Radiologic implantation of central venous portal systems in the forearm. Rofo 169:189–194PubMed
34.
Zurück zum Zitat Lenhart M, Schatzler S, Manke C, Strotzer M, Seitz J, Gmeinwieser J, Volk M, Zorger N, Feuerbach S, Herold T, Paetzel C (2010) Radiological placement of peripheral central venous access ports at the forearm. Technical results and long term outcome in 391 patients. Rofo 182:20–28PubMed Lenhart M, Schatzler S, Manke C, Strotzer M, Seitz J, Gmeinwieser J, Volk M, Zorger N, Feuerbach S, Herold T, Paetzel C (2010) Radiological placement of peripheral central venous access ports at the forearm. Technical results and long term outcome in 391 patients. Rofo 182:20–28PubMed
35.
Zurück zum Zitat Lersch C, Eckel F, Sader R, Paschalidis M, Zeilhofer F, Schulte-Frohlinde E, Theiss W (1999) Initial experience with Healthport miniMax and other peripheral arm ports in patients with advanced gastrointestinal malignancy. Oncology 57:269–275PubMedCrossRef Lersch C, Eckel F, Sader R, Paschalidis M, Zeilhofer F, Schulte-Frohlinde E, Theiss W (1999) Initial experience with Healthport miniMax and other peripheral arm ports in patients with advanced gastrointestinal malignancy. Oncology 57:269–275PubMedCrossRef
36.
Zurück zum Zitat Marcy PY, Chamorey E, Amoretti N, Benezery K, Bensadoun RJ, Bozec A, Poissonnet G, Dassonville O, Rame M, Italiano A, Peyrade F, Brenac F, Gallard JC (2008) A comparison between distal and proximal port device insertion in head and neck cancer. Eur J Surg Oncol 34:1262–1269PubMed Marcy PY, Chamorey E, Amoretti N, Benezery K, Bensadoun RJ, Bozec A, Poissonnet G, Dassonville O, Rame M, Italiano A, Peyrade F, Brenac F, Gallard JC (2008) A comparison between distal and proximal port device insertion in head and neck cancer. Eur J Surg Oncol 34:1262–1269PubMed
37.
Zurück zum Zitat Marcy PY, Magne N, Castadot P, Italiano A, Amoretti N, Bailet C, Bentolila F, Gallard JC (2007) Is radiologic placement of an arm port mandatory in oncology patients?: analysis of a large bi-institutional experience. Cancer 110:2331–2338PubMedCrossRef Marcy PY, Magne N, Castadot P, Italiano A, Amoretti N, Bailet C, Bentolila F, Gallard JC (2007) Is radiologic placement of an arm port mandatory in oncology patients?: analysis of a large bi-institutional experience. Cancer 110:2331–2338PubMedCrossRef
38.
Zurück zum Zitat McNulty NJ, Perrich KD, Silas AM, Linville RM, Forauer AR (2010) Implantable subcutaneous venous access devices: is port fixation necessary? A review of 534 cases. Cardiovasc Interv Radiol 33:751–755CrossRef McNulty NJ, Perrich KD, Silas AM, Linville RM, Forauer AR (2010) Implantable subcutaneous venous access devices: is port fixation necessary? A review of 534 cases. Cardiovasc Interv Radiol 33:751–755CrossRef
39.
Zurück zum Zitat Niederhuber JE, Ensminger W, Gyves JW, Liepman M, Doan K, Cozzi E (1982) Totally implanted venous and arterial access system to replace external catheters in cancer treatment. Surgery 92:706–712PubMed Niederhuber JE, Ensminger W, Gyves JW, Liepman M, Doan K, Cozzi E (1982) Totally implanted venous and arterial access system to replace external catheters in cancer treatment. Surgery 92:706–712PubMed
40.
Zurück zum Zitat Nishinari K, Wolosker N, Bernardi CV, Yazbek G (2010) Totally implantable ports connected to valved catheters for chemotherapy: experience from 350 Groshong devices. J Vasc Access 11:17–22PubMed Nishinari K, Wolosker N, Bernardi CV, Yazbek G (2010) Totally implantable ports connected to valved catheters for chemotherapy: experience from 350 Groshong devices. J Vasc Access 11:17–22PubMed
41.
Zurück zum Zitat Ozdemir NY, Abali H, Oksuzoglu B, Budakoglu B, Akmangit I, Zengin N (2009) It appears to be safe to start chemotherapy on the day of implantation through subcutaneous venous port catheters in inpatient setting. Support Care Cancer 17:399–403PubMedCrossRef Ozdemir NY, Abali H, Oksuzoglu B, Budakoglu B, Akmangit I, Zengin N (2009) It appears to be safe to start chemotherapy on the day of implantation through subcutaneous venous port catheters in inpatient setting. Support Care Cancer 17:399–403PubMedCrossRef
42.
Zurück zum Zitat Pardo I, Rager EL, Bowling MW, Fajardo A, Clare S, Goulet R Jr (2011) Central venous port placement: a comparison of axillary versus anterior chest wall placement. Ann Surg Oncol 18:468–471PubMedCrossRef Pardo I, Rager EL, Bowling MW, Fajardo A, Clare S, Goulet R Jr (2011) Central venous port placement: a comparison of axillary versus anterior chest wall placement. Ann Surg Oncol 18:468–471PubMedCrossRef
43.
Zurück zum Zitat Platzbecker U, Illmer T, Schaich M, Freiberg-Richter J, Helwig A, Plettig R, Jenke A, Ehninger G, Bornhauser M (2001) Double lumen port access in patients receiving allogeneic blood stem cell transplantation. Bone Marrow Transplant 28:1067–1072PubMedCrossRef Platzbecker U, Illmer T, Schaich M, Freiberg-Richter J, Helwig A, Plettig R, Jenke A, Ehninger G, Bornhauser M (2001) Double lumen port access in patients receiving allogeneic blood stem cell transplantation. Bone Marrow Transplant 28:1067–1072PubMedCrossRef
44.
Zurück zum Zitat Ponnet G, Goossens P, Oost C (1997) A comparative study between 3 venous access systems with various types of catheters. Oncologica 14:18–21PubMed Ponnet G, Goossens P, Oost C (1997) A comparative study between 3 venous access systems with various types of catheters. Oncologica 14:18–21PubMed
45.
Zurück zum Zitat Poorter RL, Lauw FN, Bemelman WA, Bakker PJ, Taat CW, Veenhof CH (1996) Complications of an implantable venous access device (Port-a-Cath) during intermittent continuous infusion of chemotherapy. Eur J Cancer 32A:2262–2266PubMedCrossRef Poorter RL, Lauw FN, Bemelman WA, Bakker PJ, Taat CW, Veenhof CH (1996) Complications of an implantable venous access device (Port-a-Cath) during intermittent continuous infusion of chemotherapy. Eur J Cancer 32A:2262–2266PubMedCrossRef
46.
Zurück zum Zitat Puig-La Calle J Jr, Lopez SS, Piedrafita SE, Allende HL, Artigas RV, Puig la CJ (1996) Totally implanted device for long-term intravenous chemotherapy: experience in 123 adult patients with solid neoplasms. J Surg Oncol 62:273–278PubMedCrossRef Puig-La Calle J Jr, Lopez SS, Piedrafita SE, Allende HL, Artigas RV, Puig la CJ (1996) Totally implanted device for long-term intravenous chemotherapy: experience in 123 adult patients with solid neoplasms. J Surg Oncol 62:273–278PubMedCrossRef
47.
Zurück zum Zitat Ramirez JM, Miguelena JM, Guemes A, Moncada E, Cabezali R, Sousa R (1993) Fully implantable venous access systems. Br J Surg 80:347–348PubMedCrossRef Ramirez JM, Miguelena JM, Guemes A, Moncada E, Cabezali R, Sousa R (1993) Fully implantable venous access systems. Br J Surg 80:347–348PubMedCrossRef
48.
Zurück zum Zitat Rubenstein EB, Fender A, Rolston KV, Elting LS, Prasco P, Palmer J, Road I, Pollock RE, Frisbee-Hume S, Laurence D (1995) Vascular access by physician assistants: evaluation of an implantable peripheral port system in cancer patients. J Clin Oncol 13:1513–1519PubMed Rubenstein EB, Fender A, Rolston KV, Elting LS, Prasco P, Palmer J, Road I, Pollock RE, Frisbee-Hume S, Laurence D (1995) Vascular access by physician assistants: evaluation of an implantable peripheral port system in cancer patients. J Clin Oncol 13:1513–1519PubMed
49.
Zurück zum Zitat Schutz JC, Patel AA, Clark TW, Solomon JA, Freiman DB, Tuite CM, Mondschein JI, Soulen MC, Shlansky-Goldberg RD, Stavropoulos SW, Kwak A, Chittams JL, Trerotola SO (2004) Relationship between chest port catheter tip position and port malfunction after interventional radiologic placement. J Vasc Interv Radiol 15:581–587PubMed Schutz JC, Patel AA, Clark TW, Solomon JA, Freiman DB, Tuite CM, Mondschein JI, Soulen MC, Shlansky-Goldberg RD, Stavropoulos SW, Kwak A, Chittams JL, Trerotola SO (2004) Relationship between chest port catheter tip position and port malfunction after interventional radiologic placement. J Vasc Interv Radiol 15:581–587PubMed
50.
Zurück zum Zitat Sehirali S, Inal MM, Ozsezgin S, Sanci M, Atli O, Nayki C, Yildirim Y, Tinar S (2005) A randomized prospective study of comparison of reservoir ports versus conventional vascular access in advanced-stage ovarian carcinoma cases treated with chemotherapy. Int J Gynecol Cancer 15:228–232PubMedCrossRef Sehirali S, Inal MM, Ozsezgin S, Sanci M, Atli O, Nayki C, Yildirim Y, Tinar S (2005) A randomized prospective study of comparison of reservoir ports versus conventional vascular access in advanced-stage ovarian carcinoma cases treated with chemotherapy. Int J Gynecol Cancer 15:228–232PubMedCrossRef
51.
Zurück zum Zitat Shetty PC, Mody MK, Kastan DJ, Sharma RP, Burke MW, Venugopal C, Burke TH (1997) Outcome of 350 implanted chest ports placed by interventional radiologists. J Vasc Interv Radiol 8:991–995PubMedCrossRef Shetty PC, Mody MK, Kastan DJ, Sharma RP, Burke MW, Venugopal C, Burke TH (1997) Outcome of 350 implanted chest ports placed by interventional radiologists. J Vasc Interv Radiol 8:991–995PubMedCrossRef
52.
Zurück zum Zitat Silberzweig JE, Sacks D, Khorsandi AS, Bakal CW (2000) Reporting standards for central venous access. Technology assessment committee. J Vasc Interv Radiol 11:391–400PubMedCrossRef Silberzweig JE, Sacks D, Khorsandi AS, Bakal CW (2000) Reporting standards for central venous access. Technology assessment committee. J Vasc Interv Radiol 11:391–400PubMedCrossRef
53.
Zurück zum Zitat Slim K, Nini E, Forestier D, Kwiatkowski F, Panis Y, Chipponi J (2003) Methodological index for non-randomized studies (minors): development and validation of a new instrument. ANZ J Surg 73:712–716PubMedCrossRef Slim K, Nini E, Forestier D, Kwiatkowski F, Panis Y, Chipponi J (2003) Methodological index for non-randomized studies (minors): development and validation of a new instrument. ANZ J Surg 73:712–716PubMedCrossRef
54.
Zurück zum Zitat Sonobe M, Chen F, Fujinaga T, Sato K, Shoji T, Sakai H, Miyahara R, Bando T, Okubo K, Hirata T, Date H (2009) Use of totally implantable central venous access port via the basilic vein in patients with thoracic malignancies. Int J Clin Oncol 14:208–212PubMedCrossRef Sonobe M, Chen F, Fujinaga T, Sato K, Shoji T, Sakai H, Miyahara R, Bando T, Okubo K, Hirata T, Date H (2009) Use of totally implantable central venous access port via the basilic vein in patients with thoracic malignancies. Int J Clin Oncol 14:208–212PubMedCrossRef
55.
Zurück zum Zitat Stevens B, Barton SE, Brechbill M, Moenter S, Piel AL, Shankle D (2000) A randomized, prospecive trial of conventional vascular ports vs.the vortex "clear-flow" reservoir port in adult oncology patients. JVAD 5(4):37–40 Stevens B, Barton SE, Brechbill M, Moenter S, Piel AL, Shankle D (2000) A randomized, prospecive trial of conventional vascular ports vs.the vortex "clear-flow" reservoir port in adult oncology patients. JVAD 5(4):37–40
56.
Zurück zum Zitat Surov A, Jordan K, Buerke M, Arnold D, John E, Spielmann RP, Behrmann C (2008) Port catheter insufficiency: incidence and clinical-radiological correlations. Onkologie 31:455–461PubMedCrossRef Surov A, Jordan K, Buerke M, Arnold D, John E, Spielmann RP, Behrmann C (2008) Port catheter insufficiency: incidence and clinical-radiological correlations. Onkologie 31:455–461PubMedCrossRef
57.
Zurück zum Zitat Teichgraber UK, Streitparth F, Cho CH, Benter T, Gebauer B (2009) A comparison of clinical outcomes with regular- and low-profile totally implanted central venous port systems. Cardiovasc Interv Radiol 32:975–979CrossRef Teichgraber UK, Streitparth F, Cho CH, Benter T, Gebauer B (2009) A comparison of clinical outcomes with regular- and low-profile totally implanted central venous port systems. Cardiovasc Interv Radiol 32:975–979CrossRef
58.
Zurück zum Zitat Vandoni RE, Guerra A, Sanna P, Bogen M, Cavalli F, Gertsch P (2009) Randomised comparison of complications from three different permanent central venous access systems. Swiss Med Wkly 139:313–316PubMed Vandoni RE, Guerra A, Sanna P, Bogen M, Cavalli F, Gertsch P (2009) Randomised comparison of complications from three different permanent central venous access systems. Swiss Med Wkly 139:313–316PubMed
59.
Zurück zum Zitat Vlasveld LT, Rodenhuis S, Rutgers EJ, Dubbelman AC, Hilton AM, Batchelor D, Rankin EM (1994) Catheter-related complications in 52 patients treated with continuous infusion of low dose recombinant interleukin-2 via an implanted central venous catheter. Eur J Surg Oncol 20:122–129PubMed Vlasveld LT, Rodenhuis S, Rutgers EJ, Dubbelman AC, Hilton AM, Batchelor D, Rankin EM (1994) Catheter-related complications in 52 patients treated with continuous infusion of low dose recombinant interleukin-2 via an implanted central venous catheter. Eur J Surg Oncol 20:122–129PubMed
60.
Zurück zum Zitat Wagner HJ, Teichgraber U, Gebauer B, Kalinowski M (2003) Transjugular implantation of venous port catheter systems. Rofo 175:1539–1544PubMed Wagner HJ, Teichgraber U, Gebauer B, Kalinowski M (2003) Transjugular implantation of venous port catheter systems. Rofo 175:1539–1544PubMed
61.
Zurück zum Zitat Wolosker N, Yazbek G, Nishinari K, Malavolta LC, Munia MA, Langer M, Zerati AE (2004) Totally implantable venous catheters for chemotherapy: experience in 500 patients. São Paulo Med J 122:147–151PubMedCrossRef Wolosker N, Yazbek G, Nishinari K, Malavolta LC, Munia MA, Langer M, Zerati AE (2004) Totally implantable venous catheters for chemotherapy: experience in 500 patients. São Paulo Med J 122:147–151PubMedCrossRef
Metadaten
Titel
Systematic review: malfunction of totally implantable venous access devices in cancer patients
verfasst von
Godelieve Alice Goossens
Marguerite Stas
Martine Jérôme
Philip Moons
Publikationsdatum
01.07.2011
Verlag
Springer-Verlag
Erschienen in
Supportive Care in Cancer / Ausgabe 7/2011
Print ISSN: 0941-4355
Elektronische ISSN: 1433-7339
DOI
https://doi.org/10.1007/s00520-011-1171-3

Weitere Artikel der Ausgabe 7/2011

Supportive Care in Cancer 7/2011 Zur Ausgabe

Umsetzung der POMGAT-Leitlinie läuft

03.05.2024 DCK 2024 Kongressbericht

Seit November 2023 gibt es evidenzbasierte Empfehlungen zum perioperativen Management bei gastrointestinalen Tumoren (POMGAT) auf S3-Niveau. Vieles wird schon entsprechend der Empfehlungen durchgeführt. Wo es im Alltag noch hapert, zeigt eine Umfrage in einem Klinikverbund.

CUP-Syndrom: Künstliche Intelligenz kann Primärtumor finden

30.04.2024 Künstliche Intelligenz Nachrichten

Krebserkrankungen unbekannten Ursprungs (CUP) sind eine diagnostische Herausforderung. KI-Systeme können Pathologen dabei unterstützen, zytologische Bilder zu interpretieren, um den Primärtumor zu lokalisieren.

Sind Frauen die fähigeren Ärzte?

30.04.2024 Gendermedizin Nachrichten

Patienten, die von Ärztinnen behandelt werden, dürfen offenbar auf bessere Therapieergebnisse hoffen als Patienten von Ärzten. Besonders gilt das offenbar für weibliche Kranke, wie eine Studie zeigt.

Adjuvante Immuntherapie verlängert Leben bei RCC

25.04.2024 Nierenkarzinom Nachrichten

Nun gibt es auch Resultate zum Gesamtüberleben: Eine adjuvante Pembrolizumab-Therapie konnte in einer Phase-3-Studie das Leben von Menschen mit Nierenzellkarzinom deutlich verlängern. Die Sterberate war im Vergleich zu Placebo um 38% geringer.

Update Onkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.